Evidence map›Paper›PMID 26637437›Full record

ReviewCold Spring Harbor perspectives in medicine2015

Neonatal and Infantile Epilepsy: Acquired and Genetic Models.

Aristea S Galanopoulou, Solomon L Moshé

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Inflammation in Epileptic Encephalopathies.Advances in protein chemistry and structural biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Aristea S GalanopoulouSaul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience, Laboratory of Developmental Epilepsy, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10461.
Solomon L MoshéSaul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience, Laboratory of Developmental Epilepsy, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10461 Department of Pediatrics, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10461.
Albert Einstein College of Medicine · USMontefiore Medical Center · US

Funding

Impact of Initial Therapy and Response on Long Term Outcome in Children with CAEU01NS045911 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI GLAUSER, TRACY A · 2003 to 2013
$31.1M
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Public Engagement CoreU54NS100064 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ENGEL, JEROME NONE, GALANOPOULOU, ARISTEA S · 2017 to 2021
$21.7M
Consequences of Prolonged Febrile Seizures in ChildhoodR01NS043209 · NINDS · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI SHINNAR, SHLOMO · 2003 to 2012
$21.5M
Consequences of Prolonged Febrile Seizures in ChildhoodR37NS043209 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHINNAR, SHLOMO · 2013 to 2019
$11.4M
AGE RELATED SEIZURE SUPPRESSIONR01NS020253 · NINDS · YESHIVA UNIVERSITY · PI MOSHE, SOLOMON L. · 1985 to 2011
$4.7M
GABA-inflammation interplay in infantile spasmsR01NS091170 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GALANOPOULOU, ARISTEA S · 2015 to 2020
$1.9M
Age related seizure suppressionR56NS020253 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI MOSHE, SOLOMON L. · 2007 to 2007
$498k
Screening for new therapies for refractory infantile spasmsR21NS078333 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI GALANOPOULOU, ARISTEA S · 2012 to 2013
$452k
NINDS NIH HHS NS078333NINDS NIH HHS NS20253NINDS NIH HHS NS43209NINDS NIH HHS NS45911NINDS NIH HHS R01 NS020253NINDS NIH HHS R01 NS043209NINDS NIH HHS R01 NS091170NINDS NIH HHS R21 NS078333NINDS NIH HHS R37 NS043209NINDS NIH HHS R56 NS020253NINDS NIH HHS U01 NS045911NINDS NIH HHS U54 NS100064
6 · The paper itself

Abstract

The incidence of seizures and epilepsies is particularly high during the neonatal and infantile periods. We will review selected animal models of early-life epileptic encephalopathies that have addressed the dyscognitive features of frequent interictal spikes, the pathogenesis and treatments of infantile spasms (IS) or Dravet syndrome, disorders with mammalian target of rapamycin (mTOR) dysregulation, and selected early-life epilepsies with genetic defects. Potentially pathogenic mechanisms in these conditions include interneuronopathies in IS or Dravet syndrome and mTOR dysregulation in brain malformations, tuberous sclerosis, and related genetic disorders, or IS of acquired etiology. These models start to generate the first therapeutic drugs, which have been specifically developed in immature animals. However, there are challenges in translating preclinical discoveries into clinically relevant findings. The advances made so far hold promise that the new insights may potentially have curative or disease-modifying potential for many of these devastating conditions.

Indexed as

AnimalsAnimals, NewbornDisease Models, AnimalEpilepsies, MyoclonicEpilepsyHumansInfant, NewbornMiceModels, GeneticNervous System MalformationsRatsSpasms, InfantileTOR Serine-Threonine KinasesTranslational Research, BiomedicalTuberous SclerosisTOR Serine-Threonine Kinases

Identifiers

PMID26637437
PMCPMC4691802
OpenAlexW2184956502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.